Return on average equity - 5 year average | 29.26 |
Revenue/employee - most recent fiscal year | 1,18,57,090.00 |
Return on average assets - most recent fiscal year | 24.20 |
Net Income/employee - trailing 12 month | 29,79,707.00 |
Return on investment - most recent fiscal year | 43.81 |
Return on investment - trailing 12 month | 43.81 |
Receivables turnover - most recent fiscal year | 14.08 |
Return on average assets - trailing 12 month | 24.20 |
Inventory turnover - most recent fiscal year | 3.00 |
Revenue/employee - trailing 12 month | 1,20,43,720.00 |
Inventory turnover - trailing 12 month | 2.76 |
Net Income/employee - most recent fiscal year | 29,33,532.00 |
Return on average equity - trailing 12 month | 49.75 |
Return on average assets - 5 year average | 15.30 |
Receivables turnover - trailing 12 month | 14.57 |
Asset turnover - trailing 12 month | 0.98 |
Return on average equity - most recent fiscal year | 49.75 |
Asset turnover - most recent fiscal year | 0.98 |
Return on investment - 5 year average | 25.66 |
Glaxosmithkline Pharmaceutical Dividend Glaxosmithkline Pharmaceutical Bonus Glaxosmithkline Pharmaceutical News Glaxosmithkline Pharmaceutical AGM Glaxosmithkline Pharmaceutical Rights Glaxosmithkline Pharmaceutical Splits Glaxosmithkline Pharmaceutical Board Meetings Glaxosmithkline Pharmaceutical Shareholdings Glaxosmithkline Pharmaceutical Profit Loss Glaxosmithkline Pharmaceutical Balance Sheet Glaxosmithkline Pharmaceutical Cashflow Glaxosmithkline Pharmaceutical Q1 Results Glaxosmithkline Pharmaceutical Q2 Results Glaxosmithkline Pharmaceutical Q3 Results Glaxosmithkline Pharmaceutical Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks